Company Filing History:
Years Active: 2025
Title: Anne Bredenbeck: Innovator in Fibroblast Activation Protein Research
Introduction
Anne Bredenbeck is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of compounds that target fibroblast activation proteins. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Anne holds a patent for her invention titled "Compounds comprising a fibroblast activation protein ligand and use thereof." This patent describes a compound that includes a cyclic peptide and a chelator, along with its various uses in medical applications. This invention showcases her expertise in creating novel compounds that can be utilized in therapeutic settings.
Career Highlights
Anne is currently employed at 3B Pharmaceuticals GmbH, where she continues to advance her research and development efforts. Her work at the company reflects her commitment to innovation in the pharmaceutical industry. With one patent to her name, she has established herself as a promising inventor in her field.
Collaborations
Anne collaborates with esteemed colleagues, including Frank Osterkamp and Dirk Zboralski. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the pharmaceutical sector.
Conclusion
Anne Bredenbeck is a pioneering inventor whose work in fibroblast activation protein research is paving the way for new therapeutic solutions. Her contributions to the field are noteworthy and demonstrate her dedication to innovation in medicine.